Markets:

Overview

News

Currencies

International

Treasuries

Alimera Sciences, Inc. - Common Stock (NQ:ALIM)

5.540 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 13, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alimera Sciences, Inc. - Common Stock

< Previous 1 2 3 Next >

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

September 11, 2024

From ANI Pharmaceuticals, Inc. and Alimera Sciences, Inc.

Via Business Wire

Crude Oil Dips Over 4%; OPEC Cuts Global Oil Demand Outlook ↗

September 10, 2024

Via Benzinga

Dow Dips Around 1%; US Small Business Optimism Falls In August ↗

September 10, 2024

Via Benzinga

Topics Stocks

Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement

September 10, 2024

From Alimera Sciences, Inc.

Via Business Wire

A Preview Of Alimera Sciences's Earnings ↗

March 06, 2024

Via Benzinga

The Latest Analyst Ratings for Alimera Sciences ↗

August 14, 2023

Via Benzinga

Preview: Alimera Sciences's Earnings ↗

August 09, 2023

Via Benzinga

Alliance Global Partners Upgrades Alimera Sciences: Here's What You Need To Know ↗

June 12, 2023

Via Benzinga

ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM

August 19, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

ALIM stock results show that Alimera Sciences missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, DOMA, ALE on Behalf of Shareholders

July 27, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, MORF, AGR on Behalf of Shareholders

July 08, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)

July 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SRDX, ATRI on Behalf of Shareholders

July 04, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRFT, SBOW, ALIM, HCP on Behalf of Shareholders

July 02, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), PlayAGS, Incorporated (NYSE - AGS), RBAZ Bancorp, Inc. (OTCPK - RBAZ)

July 01, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SHCR, AGRX on Behalf of Shareholders

June 29, 2024

From Halper Sadeh LLC

Via GlobeNewswire

ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM

June 28, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SBOW, AGR, RPHM on Behalf of Shareholders

June 25, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), SilverBow Resources, Inc. (NYSE - SBOW), Reneo Pharmaceuticals, Inc. (Nasdaq - RPHM)

June 25, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close ↗

June 25, 2024

Via Benzinga

Topics Stocks

Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher ↗

June 24, 2024

Via Benzinga

Topics Stocks

Why Is MicroAlgo (MLGO) Stock Up 113% Today? ↗

June 24, 2024

MicroAlgo stock is up on Monday after the company revealed in an SEC filing that an investor now holds an almost 14% stake in MLGO.

Via InvestorPlace

Topics Regulatory Compliance

Why Is Alimera Sciences (ALIM) Stock Up 77% Today? ↗

June 24, 2024

Alimera Sciences stock is up on Monday as investors react to a $5.50 per share acquisition offer for ALIM from ANI Pharmaceuticals.

Via InvestorPlace

Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal ↗

June 24, 2024

ANI Pharmaceuticals to acquire Alimera Sciences for $5.50 per share in cash, plus a contingent value right of up to $0.50 per share. The transaction is valued at $381 million and is expected to close...

Via Benzinga

ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

ALIM stock results show that Alimera Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

ALIM Stock Earnings: Alimera Sciences Beats Revenue for Q4 2023 ↗

March 07, 2024

ALIM stock results show that Alimera Sciences beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline

August 08, 2023

Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...

Via Newsfile

Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 ↗

June 12, 2023

Via Benzinga

Earnings Scheduled For March 7, 2024 ↗

March 07, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.